Mikael Dolsten - 18 Jun 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Mikael Dolsten
Issuer symbol
RCKT
Transactions as of
18 Jun 2025
Transactions value $
$0
Form type
4
Filing time
18 Jul 2025, 16:05:42 UTC
Previous filing
18 Mar 2025
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dolsten Mikael Director C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Mikael Dolsten 18 Jul 2025 0001437590

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Award $0 +30K +210.97% $0.00 44.2K 18 Jun 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include 14,220 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis held by the Reporting Person which cliff vest on December 31, 2025.
F2 Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026.